Patents-Review.com
🔗 Permalink
Assignee profile:

H. LUNDBECK A/S

City:

Valby

Country:

Denmark

Published Applications:

351

Last publication date:

2026-05-28

Patent Grants:

309

Last grant date:

2026-03-31

Quarterly H. LUNDBECK A/S Patent Applications

Top Inventors for applications by H. LUNDBECK A/S

These are the the leading inventors for applications assigned to H. LUNDBECK A/S:

Recent patent applications by H. LUNDBECK A/S

H. LUNDBECK A/S based in Valby, DK has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-28
US20260144795A1
Human necessities

SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS

 #2 | 2026-02-26
US20260055131A1
Chemistry; metallurgy

SOLID FORMS OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

 #3 | 2025-12-18
US20250381208A1
Human necessities

CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON’S DISEASE

 #4 | 2025-09-04
US20250277040A1
Chemistry; metallurgy

AGENT, USES AND METHODS FOR TREATMENT

 #5 | 2025-08-21 ✅ Patent 12,590,106 granted on 2026-03-31
US20250263422A1
Chemistry; metallurgy

SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS

 #6 | 2025-08-14
US20250257124A1
Chemistry; metallurgy

ANTIBODIES SPECIFIC FOR HYPERPHOSPHORYLATED TAU AND METHODS OF USE THEREOF

 #7 | 2024-12-26
US20240425521A1
Chemistry; metallurgy

SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS

 #8 | 2024-12-05 ✅ Patent 12,358,975 granted on 2025-07-15
US20240400662A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES

 #9 | 2024-12-05 ✅ Patent 12,351,624 granted on 2025-07-08
US20240400661A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES

 #10 | 2024-12-05 ✅ Patent 12,358,974 granted on 2025-07-15
US20240400660A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES

 #11 | 2024-10-24 ✅ Patent 12,398,169 granted on 2025-08-26
US20240352055A1
Chemistry; metallurgy

PROCESS FOR THE MANUFACTURE OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

 #12 | 2024-10-17
US20240343741A1
Chemistry; metallurgy

LEUCINE-RICH REPEAT KINASE 2 (LRRK2) INHIBITORS

 #13 | 2024-10-03
US20240327336A1
Chemistry; metallurgy

ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS

 #14 | 2024-08-15 ✅ Patent 12,215,144 granted on 2025-02-04
US20240270832A1
Chemistry; metallurgy

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

 #15 | 2024-07-18 ✅ Patent 12,215,145 granted on 2025-02-04
US20240239880A1
Chemistry; metallurgy

Treatment of headache using anti-CGRP antibodies

 #16 | 2024-06-13 ✅ Patent 12,421,271 granted on 2025-09-23
US20240190909A1
Chemistry; metallurgy

SOLID FORMS OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID

 #17 | 2024-05-16 ✅ Patent 12,226,428 granted on 2025-02-18
US20240156851A1
Human necessities

Catecholamine prodrugs for use in the treatment of Parkinson's disease

 #18 | 2024-04-16 ✅ Patent 11,958,865 granted on 2024-04-16
US18467162
Chemistry; metallurgy

Leucine-rich repeat kinase 2 (LRRK2) inhibitors

 #19 | 2024-03-28 ✅ Patent 12,384,837 granted on 2025-08-12
US20240101653A1
Chemistry; metallurgy

TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES

 #20 | 2024-03-14
US20240082239A1
Human necessities

Therapeutic Uses of Compounds Having Combined Sert, 5-HT3 and 5-HT1a Activity

 #21 | 2024-03-07 ✅ Patent 12,391,749 granted on 2025-08-19
US20240076359A1
Chemistry; metallurgy

ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

 #22 | 2024-02-29 ✅ Patent 12,384,836 granted on 2025-08-12
US20240067708A1
Chemistry; metallurgy

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

 #23 | 2024-01-25 ✅ Patent 12,077,578 granted on 2024-09-03
US20240025979A1
Chemistry; metallurgy

Compositions and methods for treating synucleinopathies

 #24 | 2024-01-25
US20240025857A1
Chemistry; metallurgy

NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE

 #25 | 2024-01-18 ✅ Patent 12,479,801 granted on 2025-11-25
US20240018107A1
Chemistry; metallurgy

PROCESS FOR THE MANUFACTURING OF (6AR,10AR)-7-PROPYL-6,6A,7,8,9,10,10A,11-OCTAHYDRO-[1,3]DIOXOLO[4',5':5,6]BENZO[1,2-G]QUINOLINE AND (4AR,10AR)-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDRO-BENZO[G]QUINOLINE-6,7-DIOL

 #26 | 2023-12-28 ✅ Patent 11,993,612 granted on 2024-05-28
US20230416272A1
Chemistry; metallurgy

LRRK2 inhibitors

 #27 | 2023-11-09 ✅ Patent 12,378,219 granted on 2025-08-05
US20230357190A1
Chemistry; metallurgy

CRYSTALLINE FORMS OF A MAGL INHIBITOR

 #28 | 2023-10-05 ✅ Patent 12,018,004 granted on 2024-06-25
US20230312499A1
Chemistry; metallurgy

Carbamate compounds and methods of making and using same

 #29 | 2023-08-24 ✅ Patent 12,152,029 granted on 2024-11-26
US20230265095A1
Chemistry; metallurgy

Crystalline forms of a MAGL inhibitor

 #30 | 2023-07-13 ✅ Patent 12,258,340 granted on 2025-03-25
US20230219897A1
Chemistry; metallurgy

Pyrazole MAGL inhibitors

 #31 | 2023-06-08 ✅ Patent 12,351,627 granted on 2025-07-08
US20230174641A1
Chemistry; metallurgy

ANTI-ACTH ANTIBODIES AND USE THEREOF

 #32 | 2023-05-25 ✅ Patent 12,331,123 granted on 2025-06-17
US20230159643A1
Chemistry; metallurgy

AGENT, USES AND METHODS FOR TREATMENT

 #33 | 2023-05-25 ✅ Patent 12,071,416 granted on 2024-08-27
US20230159478A1
Chemistry; metallurgy

Prodrugs of 4-( (1R, 3S)-6-chloro-3-phenyl-2, 3-dihydro-1H-inden-1-yl)-1,2, 2-trimethylpiperazine and 4-( (1R, 3S)-6-chloro-3-(phenyl-D5)-2, 3-dihydro-1H-inden-1-yl)-2, 2-dimethyl-1 (methyl-D3) piperazine

 #34 | 2023-05-11 ✅ Patent 11,780,851 granted on 2023-10-10
US20230144725A1
Chemistry; metallurgy

LRRK2 inhibitors

 #35 | 2023-04-27 ✅ Patent 12,545,725 granted on 2026-02-10
US20230125604A1
Chemistry; metallurgy

ANTI-PACAP ANTIBODIES AND USES THEREOF

 #36 | 2022-12-01 ✅ Patent 12,258,305 granted on 2025-03-25
US20220380300A1
Chemistry; metallurgy

Alcohol derivatives as Kv7 potassium channel openers

 #37 | 2022-09-15 ✅ Patent 12,077,581 granted on 2024-09-03
US20220289836A1
Chemistry; metallurgy

Anti-PACAP antibodies and uses thereof

 #38 | 2022-09-08 ✅ Patent 12,508,239 granted on 2025-12-30
US20220280455A1
Human necessities

ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE IN EPILEPSY OR SEIZURES

 #39 | 2022-08-18 ✅ Patent 11,707,476 granted on 2023-07-25
US20220257623A1
Human necessities

Catecholamine prodrugs for use in the treatment of parkinson's disease

 #40 | 2022-08-11 ✅ Patent 12,630,614 granted on 2026-05-19
US20220251178A1
Chemistry; metallurgy

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIESHEREOF

 #41 | 2022-07-28 ✅ Patent 11,993,588 granted on 2024-05-28
US20220235037A1
Chemistry; metallurgy

Crystalline forms of a MAGL inhibitor

 #42 | 2022-07-14 ✅ Patent 12,391,650 granted on 2025-08-19
US20220220077A1
Chemistry; metallurgy

NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE

 #43 | 2022-07-07 ✅ Patent 12,319,710 granted on 2025-06-03
US20220213136A1
Chemistry; metallurgy

Catecholamine prodrugs for use in the treatment of Parkinson's diseases

 #44 | 2022-07-07
US20220213117A1
Chemistry; metallurgy

PRODRUGS OF MODULATORS OF THE NMDA RECEPTOR

 #45 | 2022-07-07 ✅ Patent 12,384,765 granted on 2025-08-12
US20220213071A1
Chemistry; metallurgy

NEW CATECHOLAMINE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE

 #46 | 2022-07-07 ✅ Patent 12,398,106 granted on 2025-08-26
US20220213040A1
Chemistry; metallurgy

CATECHOLAMINE CARBAMATE PRODRUGS FOR USE IN THE TREATMENT OF PARKINSON'S DISEASE

 #47 | 2022-06-23 ✅ Patent 11,851,456 granted on 2023-12-26
US20220194978A1
Chemistry; metallurgy

Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

 #48 | 2022-06-16
US20220187322A1
Physics

USE OF A PS396 ASSAY TO DIAGNOSE TAUOPHATIES

 #49 | 2022-06-16 ✅ Patent 11,731,999 granted on 2023-08-22
US20220185839A1
Chemistry; metallurgy

Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

 #50 | 2022-06-09 ✅ Patent 12,129,289 granted on 2024-10-29
US20220177557A1
Chemistry; metallurgy

Antibodies specific for hyperphosphorylated tau and methods of use thereof

 #51 | 2022-05-19 ✅ Patent 11,434,222 granted on 2022-09-06
US20220153721A1
Chemistry; metallurgy

MAGL inhibitors

 #52 | 2022-04-21 ✅ Patent 12,116,355 granted on 2024-10-15
US20220119362A1
Chemistry; metallurgy

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

 #53 | 2022-03-10 ✅ Patent 12,428,475 granted on 2025-09-30
US20220073606A1
Chemistry; metallurgy

HUMANIZED ANTI-ACTH ANTIBODIES AND USE THEREOF

 #54 | 2022-02-03 ✅ Patent 11,535,600 granted on 2022-12-27
US20220033367A1
Chemistry; metallurgy

Prodrugs of 4-((1R,3S)-6-chloro-3-phenyl-2,3-dihydro-1H-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1R,3S)-6-chloro-3-(phenyl-d)-2,3-dihydro-1H-inden-1-yl)-2,2-dimethyl-1-(methyl-d)piperazine

 #55 | 2022-01-27 ✅ Patent 11,858,954 granted on 2024-01-02
US20220024962A1
Chemistry; metallurgy

Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

 #56 | 2022-01-27 ✅ Patent 11,866,410 granted on 2024-01-09
US20220024875A1
Chemistry; metallurgy

Process for the manufacturing of (6AR,10AR)-7-propyl-6,6A,7,8,9,10,10A,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4AR, 10AR)-1-propyl-1,2,3,4,4A,5,10,10A-octahydro-benzo[G]quinoline-6,7-diol

 #57 | 2021-10-21 ✅ Patent 11,993,648 granted on 2024-05-28
US20210324068A1
Chemistry; metallurgy

Screening method for identifying anti-PACAP antibodies or antibody fragments suitable for use in treating or preventing PACAP-associated photophobia or light aversion

 #58 | 2021-10-21 ✅ Patent 11,702,393 granted on 2023-07-18
US20210323938A1
Chemistry; metallurgy

Synthesis of a monoacylglycerol lipase inhibitor

 #59 | 2021-09-30 ✅ Patent 11,549,871 granted on 2023-01-10
US20210302282A1
Physics

Apparatus and method for isolation and/or preparation of particles

 #60 | 2021-09-23
US20210292414A1
Chemistry; metallurgy

AGENTS, USES AND METHODS FOR TREATMENT

 #61 | 2021-09-09 ✅ Patent 12,162,936 granted on 2024-12-10
US20210277106A1
Chemistry; metallurgy

Methods of treatment with anti-PACAP antibodies

 #62 | 2021-09-02 ✅ Patent 11,548,950 granted on 2023-01-10
US20210269524A1
Chemistry; metallurgy

Agent, uses and methods for treatment

 #63 | 2021-08-05 ✅ Patent 11,472,810 granted on 2022-10-18
US20210238182A1
Chemistry; metallurgy

Imidazopyrazinones as PDE1 inhibitors

 #64 | 2021-08-05 ✅ Patent 12,421,303 granted on 2025-09-23
US20210236634A1
Human necessities

AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY

 #65 | 2021-07-15 ✅ Patent 11,161,856 granted on 2021-11-02
US20210214375A1
Chemistry; metallurgy

Spirocycle compounds and methods of making and using same

 #66 | 2021-07-08 ✅ Patent 11,739,140 granted on 2023-08-29
US20210206843A1
Chemistry; metallurgy

Antibodies specific for hyperphosphorylated tau and methods of use thereof

 #67 | 2021-07-08 ✅ Patent 11,332,453 granted on 2022-05-17
US20210206735A1
Chemistry; metallurgy

MAGL inhibitors

 #68 | 2021-06-17 ✅ Patent 11,938,185 granted on 2024-03-26
US20210179688A1
Chemistry; metallurgy

Treatment of headache, migraine and/or photophobia conditions using humanized anti-PACAP antibodies

 #69 | 2021-05-20 ✅ Patent 11,421,024 granted on 2022-08-23
US20210147522A1
Chemistry; metallurgy

Agents, uses and methods for the treatment of synucleinopathy

 #70 | 2021-04-01 ✅ Patent 11,608,342 granted on 2023-03-21
US20210094960A1
Chemistry; metallurgy

PDE9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases

 #71 | 2021-04-01 ✅ Patent 11,628,166 granted on 2023-04-18
US20210093631A1
Human necessities

Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1a activity

 #72 | 2021-03-04 ✅ Patent 11,542,323 granted on 2023-01-03
US20210061892A1
Chemistry; metallurgy

Agents, uses and methods for the treatment of synucleinopathy

 #73 | 2021-02-25 ✅ Patent 11,524,995 granted on 2022-12-13
US20210054057A1
Chemistry; metallurgy

Agents, uses and methods for the treatment of synucleinopathy

 #74 | 2021-02-25 ✅ Patent 11,655,217 granted on 2023-05-23
US20210053960A1
Chemistry; metallurgy

Pyrazole MAGL inhibitors

 #75 | 2021-02-18 ✅ Patent 11,358,971 granted on 2022-06-14
US20210047342A1
Chemistry; metallurgy

Prodrugs of modulators of the NMDA receptor

 #76 | 2021-02-04 ✅ Patent 11,548,849 granted on 2023-01-10
US20210032196A1
Chemistry; metallurgy

Alcohol derivatives as KV7 potassium channel openers

 #77 | 2021-01-28 ✅ Patent 11,026,923 granted on 2021-06-08
US20210023056A1
Human necessities

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

 #78 | 2021-01-21 ✅ Patent 11,026,924 granted on 2021-06-08
US20210015794A1
Human necessities

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

 #79 | 2021-01-14 ✅ Patent 11,535,611 granted on 2022-12-27
US20210009571A1
Chemistry; metallurgy

Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitors

 #80 | 2021-01-07 ✅ Patent 11,466,027 granted on 2022-10-11
US20210002292A1
Chemistry; metallurgy

Modulators of the NMDA receptor

 #81 | 2020-12-17 ✅ Patent 11,130,775 granted on 2021-09-28
US20200392176A1
Chemistry; metallurgy

Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

 #82 | 2020-12-10 ✅ Patent 11,634,416 granted on 2023-04-25
US20200385381A1
Chemistry; metallurgy

Combination treatments comprising administration of 1H-pyrazolo[4,3-b]pyridines

 #83 | 2020-12-10 ✅ Patent 11,851,425 granted on 2023-12-26
US20200385372A1
Chemistry; metallurgy

Combination treatments comprising administration of 1H-pyrazolo[4,3-B]pyridines

 #84 | 2020-12-03
US20200375950A1
Human necessities

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

 #85 | 2020-11-26 ✅ Patent 11,111,263 granted on 2021-09-07
US20200369706A1
Chemistry; metallurgy

Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

 #86 | 2020-11-26 ✅ Patent 11,104,697 granted on 2021-08-31
US20200369705A1
Chemistry; metallurgy

Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

 #87 | 2020-11-26 ✅ Patent 11,168,056 granted on 2021-11-09
US20200369615A1
Chemistry; metallurgy

Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol

 #88 | 2020-11-26 ✅ Patent 11,642,341 granted on 2023-05-09
US20200368227A1
Human necessities

Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders

 #89 | 2020-11-19 ✅ Patent 11,491,140 granted on 2022-11-08
US20200360343A1
Human necessities

1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors

 #90 | 2020-10-29 ✅ Patent 11,110,110 granted on 2021-09-07
US20200338102A1
Human necessities

Catecholamine prodrugs for use in the treatment of Parkinson's disease

 #91 | 2020-10-08 ✅ Patent 11,427,631 granted on 2022-08-30
US20200317772A1
Chemistry; metallurgy

Anti-ACTH antibodies and use thereof

 #92 | 2020-09-24 ✅ Patent 11,639,381 granted on 2023-05-02
US20200299368A1
Chemistry; metallurgy

Treatment of headache using anti-CGRP antibodies

 #93 | 2020-09-17 ✅ Patent 11,059,822 granted on 2021-07-13
US20200291023A1
Chemistry; metallurgy

MAGL inhibitors

 #94 | 2020-09-03 ✅ Patent 11,529,357 granted on 2022-12-20
US20200276207A1
Human necessities

Injectable carbamazepine composition essentially free of 10-bromo-carbamazepine

 #95 | 2020-08-13 ✅ Patent 11,142,526 granted on 2021-10-12
US20200255427A1
Chemistry; metallurgy

Spirocycle compounds and methods of making and using same

 #96 | 2020-07-16 ✅ Patent 12,590,142 granted on 2026-03-31
US20200223913A1
Chemistry; metallurgy

ANTIBODY PURIFICATION AND PURITY MONITORING

 #97 | 2020-07-16 ✅ Patent 11,332,478 granted on 2022-05-17
US20200223865A1
Chemistry; metallurgy

Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol

 #98 | 2020-07-09 ✅ Patent 11,639,380 granted on 2023-05-02
US20200216524A1
Chemistry; metallurgy

Acute treatment and rapid treatment of headache using anti-CGRP antibodies

 #99 | 2020-06-18 ✅ Patent 10,889,650 granted on 2021-01-12
US20200190188A1
Chemistry; metallurgy

Agent, uses and methods for treatment

 #100 | 2020-06-18 ✅ Patent 10,934,348 granted on 2021-03-02
US20200190178A1
Chemistry; metallurgy

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Also check out H. Lundbeck A/S's (Valby, Denmark) applicant profile with 247 patent applications submitted.

AssigneeID:

30905 ⎘